Skip to main content

Table 2 Biospecimens collected from each patient cohort

From: Establishment of a pediatric COVID-19 biorepository: unique considerations and opportunities for studying the impact of the COVID-19 pandemic on children

Total number of samples
(N = 972)
Blood
(n = 295)
Oropharyngeal swab
(n = 181)
Nasopharyngeal swab
(n = 145)
Stool
(n = 172)
Urine
(n = 154)
Tracheal aspirate
(n = 4)
Sputum/saliva
(n = 21)
Urgent Care 86 105 79 0 3 0 7
Hospitalized 147 43 44 46 58 3 10
Newborn 55 29 19 126 93 1 0
Well visit 7 4 3 0 0 0 4
  1. All enrolled participants provided clinical and demographic data. Enrolled subjects had the option of selecting which biospecimens they would like to provide. Stool and urine were not collected from participants enrolled in the Urgent Care and Well-Visit cohorts for logistic reasons, unless these individuals were later hospitalized for COVID-19-related illness. Enrolled subjects could also consent to provide specimens, then later decline any or all specimen collection. Repeat biospecimen collection could occur if participants re-presented to care, or if hospitalized for multiple consecutive days
\